Alison Way
Senior Vice President, Investor Relations and Corporate Communications
Replay available
Xeris Biopharma Holdings, Inc. (XERS) Q3 2025 Earnings Call
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John Shannon
Chief Executive Officer
Steve Piper
Chief Financial Officer
Dennis Ding
Analyst, Jefferies
Chase Knickerbocker
Analyst, Craig-Hallum Capital Group
Leyland Gershill
Analyst, Oppenheimer & Co.
Brandon Foulkes
Analyst, H.C. Wainwright & Co.
Rorana Ruiz
Analyst, Believe, Inc. Partners
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Xeris Biopharma Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.402 -- 00:00:05.628 Hello everyone, and thank you for joining us today for the Xeris Biopharma Q3 2025 Earnings 00:00:05.628 -- 00:00:09.613 Conference Call. My name is Sammy and I'll be coordinating your call today. 00:00:09.613 -- 00:00:12.997 During the presentation, you can register a question by pressing star followed by one 00:00:12.997 -- 00:00:17.081 on your telephone keypad. If you change your mind, please press star followed by two 00:00:17.081 -- 00:00:20.605 on your telephone keypad to remove yourself from the question queue. 00:00:20.605 -- 00:00:24.430 I'd now like to hand over to your host, Alison Way, Senior Vice President of Investor 00:00:24.430 -- 00:00:27.133 Relations and Corporate Communications to begin. 00:00:27.133 -- 00:00:29.613 Please go ahead, Alison. 00:00:29.613 -- 00:00:33.797 Thank you, Sammy. Good morning and welcome, everyone, to the Xeris Biopharma Third Quarter 00:00:33.797 -- 00:00:38.862 2025 Earnings Call. You can find this morning's earnings release and our 00:00:38.862 -- 00:00:43.167 detailed financial results on the investor relations section of our website. 00:00:43.167 -- 00:00:47.571 Today, I'm joined by John Shannon, CEO, and Steve Piper, our CFO. 00:00:47.571 -- 00:00:51.055 After our prepared remarks, we'll open the line for questions. 00:00:51.055 -- 00:00:55.699 Before we begin, I'd like to remind you that this call will contain certain forward-looking 00:00:55.699 -- 00:01:00.505 statements concerning the company's future expectations plans, projects, and financial 00:01:00.505 -- 00:01:05.530 performance. Forward-looking statements are subject to risks and uncertainty and could 00:01:05.530 -- 00:01:10.035 cause actual results to differ materially from those forward-looking statements. 00:01:10.035...